GIT - Drugs used for Acid-Peptic Diseases Flashcards
Classes of drugs used for acid-peptic diseases & examples
Agents that reduce intra-gastric acidity
- Antacids (NaHCO3, CaCO3, Mg(OH)2, Al(OH)3)
- H2 Receptor Antagonists - H2 Blockers (Ranitidine, Famotidine)
- Proton Pump Inhibitor (Omeprazole)
Mucosal Protective Agents
- Sucralfate (salt of sucrose complexed to sulfate Al(OH)3)
- Bismuth Compounds (Bismuth subsalicylate, Bismuth subcitrate potassium)
- Synthetic PGE1 analog (Misoprostol)
Treatment for H. pylori eradication
Mechanism of action of antacids
Neutralize gastric acid to form salt & H2O - decreases gastric acidity but does not prevent gastric acid production
Rate of neutralization: NaHCO3 > CaCO3 > Mg(OH)2 > Al(OH)3
Uses of antacids
Non-prescription remedy for heartburn & dyspepsia
Toxicity of antacids (6)
- Na - Fluid retention, CHF, HTN
- Ca - Hypercalcemia, rebound acid secretion
- HCO3, CO3 - CO2 gas formation - gastric distension, belching
- Metabolic Alkalosis, Milk-alkali Syndrome
- Mg - Osmotic diarrhea
- Al - Constipation
Mg & Al - combined formulation to minimize impact on bowel function
Contraindications of antacids (2)
- Patients with renal insufficiency
2. Affects absorption of other medications - do not give within 2h of other drugs
Mechanism of action of H2 blockers
Competitive inhibition of H2 receptors on parietal cells - suppresses gastric acid secretion & pepsin concentration induced by histamine, gastrin and acetylcholine
Uses of H2 blockers (2)
- Nocturnal acid secretion (due to histamine) - very effective
- Meal-induced acid secretion (gastrin & ACh) - modest effect
Toxicity of H2 blockers (3)
- Mental Confusion - in critically ill patients/in renal/hepatic dysfunction
- Anti-androgenic, inhibits estradiol metab, increases serum prolactin - gynecomastia, impotence, galactorrhea
- Inhibits cytochrome P450 - prolongs half life of other drugs eg warfarin, theophylline
Mechanism of action of PPI
- Inhibits H/K ATPase in parietal cells - most potent gastric acid secretion inhibitor
- forms covalent disulphide bond, inhibits active pumps for their entire lifespan, takes 3-4 days to fully inhibit acid secretion - Has some anti-microbial activity against H. pylori
Toxicity of PPI
Generally safe
- Headache, nausea, constipation, flatulence, diarrhea
Unproven safety concerns
- Vit B12 deficiency, Fe & Ca deficiency & risk of osteoporosis, enteric Clostridium difficile infection, pneumonia, gastric cancer
Mechanism of action of sucralfate
- Negatively charged sucrose sulfate binds to positively charged proteins at ulcer crater - forms a viscous, tenacious gel that prevents further acid attack
- Stimulates mucosal prostaglandin (mainly PGE2) & bicarbonate secretion
Uses of sucralfate
- Prevents stress-related bleeding in critically ill patients
Toxicity of sucralfate (2)
- Constipation (due to Al salt)
2. Impairs absorption of other drugs (large molecule)
Mechanism of action of bismuth compounds
- Forms a protective layer coating ulcer beds against acid & pepsin
- Stimulates prostaglandin, mucus & bicarbonate secretion
- Direct anti-microbial activity against H. pylori
Uses of bismuth compounds (3)
Bismuth subsalicylate (OTC)
- Dyspepsia
- Acute diarrhea, Traveler’s diarrhea (anti-microbial effects binds enterotoxins)
Bismuth subcitrate potassium
3. Quadruple therapy for eradication of H, pylori